✦ LIBER ✦

Adjuvant Radiation for Bladder Cancer: A Dosimetry Study

✍ Scribed by Noa, K.; Dolney, D.; Baumann, B.; Bekelman, J.; Deville, C.; Vapiwala, N.; Both, S.; Kassaee, A.; Christodouleas, J.

Book ID: 123320618
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 48 KB
Volume: 84
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.07.1111

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant “sandwich” radiation therapy fo

Adjuvant “sandwich” radiation therapy for bladder cancer

✍ M. Mohiuddin; S. Kramer; G. Strong 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 415 KB

Bladder Cancer Patterns of Pelvic Failur

Bladder Cancer Patterns of Pelvic Failure: Implications for Adjuvant Radiation Therapy

✍ B.C. Baumann; T. Guzzo; D. Vaughn; S. Keefe; N. Vapiwala; C. Deville; J. Bekelma 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Bladder Cancer Patterns of Pelvic Failur

Bladder Cancer Patterns of Pelvic Failure: Implications for Adjuvant Radiation Therapy

✍ Baumann, Brian C.; Guzzo, Thomas J.; He, Jiwei; Vaughn, David J.; Keefe, Stephen 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 280 KB

BLADDER CANCER RISK FOLLOWING PRIMARY AN

BLADDER CANCER RISK FOLLOWING PRIMARY AND ADJUVANT EXTERNAL BEAM RADIATION FOR PROSTATE CANCER

✍ CHROUSER, K; LEIBOVICH, B; BERGSTRALH, E; ZINCKE, H; BLUTE, M 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 71 KB

Bladder Cancer Risk Following Primary an

Bladder Cancer Risk Following Primary and Adjuvant External Beam Radiation for Prostate Cancer

✍ Chrouser, Kristin; Leibovich, Bradley; Bergstralh, Erik; Zincke, Horst; Blute, M 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 74 KB

Adjuvant chemotherapy for invasive bladd

Adjuvant chemotherapy for invasive bladder cancer

✍ Yasunari Uekado; Toshiaki Shinka; Atsuyuki Hirano; Tadashi Ohkawa 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 388 KB

From June 1982 through December 1985, 25 patients who had undergone radical cystectomy with pelvic node dissection for pathologic stage-pT3 or -pT4 and/or N+ disease received adjuvant chemotherapy involving the injection of cis-platinum alone or in combination with adriamycin and 5-fluorouracil (CAF